Sept 3 Japan's Dainippon Sumitomo Pharma Co Ltd
(4506.T) plans to launch a bid to acquire Sepracor Inc SEPR.O
for about 250 billion yen ($2.70 billion), the Nikkei business
Shares of Marlborough, Massachusetts-based Sepracor jumped
as much as 30 percent to $23.37 Wednesday on Nasdaq.
The move is intended to boost Dainippon Sumitomo Pharma's
lineup of central nervous system and other drugs, the paper
said without citing sources.
Sepracor officials were not immediately available for
Funding for the purchase will come from sources including
cash on hand and loans, the Nikkei said.
For the alerts, double-click [ID:nWNAB6130]
(Reporting by Anand Basu in Bangalore; Editing by Anthony